Development of a self-administered questionnaire to screen patients for cervical myelopathy.

[neuralgic amyotrophy]

In primary care , it is often difficult to diagnose cervical myelopathy . However , a delay in treatment could cause irreversible aftereffects . With a brief and effective self-administered questionnaire for cervical myelopathy , cervical myelopathy may be screened more easily and oversight may be avoided . As there is presently no screening tool for cervical myelopathy , the aim of this study was to develop a self-administered questionnaire for the screening of cervical myelopathy .A case-control study was performed with the following two groups at our university hospital from February 2006 to September 2008 . Sixty -two patients (48 men , 14 women ) with cervical myelopathy who underwent operative treatment were included in the myelopathy group . In the control group , 49 patients (20 men , 29 women ) with symptoms that could be distinguished from those of cervical myelopathy , such as numbness , pain in the upper extremities , and manual clumsiness , were included . The underlying conditions were diagnosed as carpal tunnel syndrome , cubital tunnel syndrome , thoracic outlet syndrome , tarsal tunnel syndrome , diabetes mellitus neuropathy , cervical radiculopathy , and neuralgic amyotrophy . Twenty items for a questionnaire in this study were chosen from the Japanese Orthopaedic Association Cervical Myelopathy Evaluation Questionnaire , which is a new self-administered questionnaire , as an outcome measure for patients with cervical myelopathy . Data were analyzed by univariate analysis using the chi -square test and by multiple logistic regression analysis . According to the resulting odds ratio , Î²-coefficients , and p value , items were chosen and assigned a score .Eight items were chosen by univariate and multiple logistic regression analyses and assigned a score . The Hosmer-Lemeshow statistic showed p = 0 .805 . The area under the receiver operation characteristic curve was 0 .86 . The developed questionnaire had a sensitivity of 93 .5 % and a specificity of 67 .3 %.We successfully developed a simple self-administered questionnaire to screen for cervical myelopathy .

Diseases
Validation

Diseases presenting "as an outcome measure for patients with cervical myelopathy" symptom

neuralgic amyotrophy

You can validate or delete this automatically detected symptom